Chief Financial Officer of Nurix Therapeutics, Inc. (NASDAQ:NRIX), Van Houte Hans, sells 5,330 shares worth $212,839
According to Nurix Therapeutics, Inc.'s most recent Statement Of Changes In Beneficial Ownership - Form 4 filing with the SEC dated Feb 23 06:04 PM, company Chief Financial Officer, Van Houte Hans disclosed selling 5,330 shares at a cost of $39.93. At the time of this transaction (Feb 22), this trade was worth $212,839 in total. As of Feb 22, Van Houte Hans now owns 0 shares in total worth about $0.0.
For the last few recent trades made by Nurix Therapeutics, Inc. (NASDAQ:NRIX) Chief Financial Officer, Van Houte Hans, we have the following information:
- SEC Form 4 filing: Feb 18: Sold 13,583 shares at the rate of $35.46 per share. Total worth of this trade was $481,621. Total number of shares owned as of Feb 18 were 0
Posted by
George Daniels
on Tuesday February 23 2021, 8:45 PM EDT.
All trademarks acknowledged.
Filed under Business, Stocks.
Comments and Trackbacks closed.
Follow responses:
RSS 2.0
